Home/Filings/4/0000899243-17-006500
4//SEC Filing

BIODELIVERY SCIENCES INTERNATIONAL INC 4

Accession 0000899243-17-006500

CIK 0001103021operating

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 7:19 PM ET

Size

22.4 KB

Accession

0000899243-17-006500

Insider Transaction Report

Form 4
Period: 2017-02-22
Vasisht Niraj
Chief Technology Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-02-23+66,667253,969 total
  • Exercise/Conversion

    Common Stock

    2017-03-01+50,000280,469 total
  • Exercise/Conversion

    Common Stock

    2017-02-22+24,980196,802 total
  • Sale

    Common Stock

    2017-02-22$2.01/sh9,500$19,095187,302 total
  • Sale

    Common Stock

    2017-02-23$1.95/sh23,500$45,825230,469 total
  • Sale

    Common Stock

    2017-03-01$2.03/sh9,000$18,270271,469 total
  • Exercise/Conversion

    Restricted Stock Units

    2017-02-22+24,9800 total
    Exercise: $0.00From: 2017-02-22Exp: 2017-02-22Common Stock (24,980 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2017-02-23+66,66766,666 total
    Exercise: $0.00From: 2017-02-23Exp: 2018-02-23Common Stock (66,667 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2017-03-01+50,000100,000 total
    Exercise: $0.00From: 2017-03-01Exp: 2019-03-01Common Stock (50,000 underlying)
Footnotes (7)
  • [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of the remaining RSUs that had been granted to the Reporting Person on February 22, 2014 under the Issuer's 2011 Equity Incentive Plan, as amended (the "Plan").
  • [F2]The shares of common stock were sold upon expiration of a pre-planned 10b5-1 trading plan, and were sold to cover the Reporting Person's additional tax liability upon the vesting of the RSUs.
  • [F3]On February 22, 2017, the Reporting Person sold an aggregate of 9,500 shares of the Issuer's Common Stock at a weighted average price of $2.01 per share. The highest sale price for the Common Stock was $2.06 per share and the lowest sale price was $1.96 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 23, 2015 under the Plan. The remainder of the RSUs under this grant will vest on February 23, 2018.
  • [F5]On February 23, 2017, the Reporting Person sold an aggregate of 23,500 shares of the Issuer's Common Stock at a weighted average price of $1.95 per share. The highest sale price for the Common Stock was $2.05 per share and the lowest sale price was $1.90 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 29, 2016 under the Plan. The remainder of the RSUs under this grant will vest in equal installments on March 1, 2018 and March 1, 2019.
  • [F7]On March 1, 2017, the Reporting Person sold an aggregate of 9,000 shares of the Issuer's Common Stock at a weighted average price of $2.03 per share. The highest sale price for the Common Stock was $2.05 per share and the lowest sale price was $2.00 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

BIODELIVERY SCIENCES INTERNATIONAL INC

CIK 0001103021

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001103021

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:19 PM ET
Size
22.4 KB